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Mycotoxins are secondary metabolites produced by toxigenic fungi in crops worldwide. In (micro)organisms such as plants, 
fungi, bacteria, or animals they may be further metabolised and modified, but this is also true for food processing, which 
may lead to a wide range of masked mycotoxin forms. These often remain undetected by analytical methods and are the 
culprits for underestimates in risk assessments. Furthermore, once ingested, modified mycotoxins can convert back to 
their parent forms. This concern has raised the need for analytical methods that can detect and quantify modified mycotoxins 
as essential for accurate risk assessment. The promising answer is liquid chromatography-mass spectrometry. New masked 
mycotoxin forms are now successfully detected by iontrap, time-of-flight, or high-resolution orbitrap mass spectrometers. 
However, the toxicological relevance of modified mycotoxins has not been fully clarified.
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Global concern about the contamination of agricultural 
commodities with mycotoxins, secondary fungal 
metabolites, has increased over the last years (1-3). 
Although the total number of mycotoxins is unknown, it is 
estimated that there are thousands of fungal secondary 
metabolites, but only a few hundred have been documented 
as toxic at low amounts. This low-amount toxicity is what 
sets mycotoxins apart from other secondary metabolites, 
such as ethanol. Ethanol is not a mycotoxin, even though 
it is a secondary fungal metabolite (4). The United Nations 
Food and Agriculture Organization (FAO) has estimated 
that about 25 % of the crops worldwide are contaminated 
with mycotoxins (1, 5). Recent reports, however, indicate 
that the contamination of commodities (cereals and feed) 
is much higher: roughly 80 % (1, 5, 6). These figures are 
expected to rise with the use of more sensitive detection 
methods and equipment, which will increase the mycotoxin 
database and standards.
The most important fungal genera producing mycotoxins 
are Aspergillus, Fusarium, Alternaria, and Penicillium (6) 
(Figure 1) and the most relevant mycotoxins for animal and 
human health worldwide are aflatoxins B1 (AFT B1), B2 
(AFT B2), G1 (AFT G1), G2 (AFT G2), and M1 (AFT M1), 
ochratoxin A (OTA), zearalenone (ZEN), deoxynivalenol 
(DON), T-2 and HT-2 toxins, fumonisins B1 (FB1) and B2 
(FB2), and patulin. The European Union has regulated their 
maximum levels in certain foodstuffs in the Commission 
Regulation (EC) No. 1881/2006 (8) and the Commission 
Recommendation 2013/165/EU (9).
Toxicity syndromes resulting from the intake of 
mycotoxins by humans and animals are known as 
mycotoxicoses (10). In some cases, the manifested clinical 
symptoms of a mycotoxicosis are significantly greater than 
expected from food or feed contamination level. This has 
led to the discovery of the so-called masked mycotoxins, 
which, as their name implies, escape detection by 
conventional analytical methods, initially developed for 
specific mycotoxins (7, 11).
As the term masked mycotoxins has often been used for 
all conjugated mycotoxins generated by or present in plants, 
animals, fungi, and food processing, Rychlik et al. (12) 
proposed a systematic four-tier hierarchy displayed in 
Figure 2 (11-13). The first tier distinguishes free mycotoxins 
from matrix-associated mycotoxins and mycotoxins with 
modified basic chemical structure. The second tier further 
distinguishes biologically modified mycotoxins from the 
chemically modified ones. The third tier includes 
biologically modified compounds that are divided into 
functionalised, conjugated, and differently modified 
mycotoxins. Finally, the fourth tier, which consists of the 
biologically conjugated mycotoxins, is divided into plant, 
animal, and fungal conjugates (12). This system, however, 
is sometimes difficult to use, since some masked forms can 
be synthesised by both fungi and plants (e.g. zearalenone 
sulphate) (14).
The presence of modified mycotoxins in cereals had 
long been speculated, until Schneweis et al. (15) 
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demonstrated modified zearalenone-14-glucoside 
(ZEN14Glc) (Figure 3) in naturally contaminated wheat. 
Three years later, Berthiller et al. (16) reported another 
mycotoxin glucoside in naturally infected cereals, 
deoxynivalenol-3-glucoside (DON3Glc) (Figure 3). Years 
that followed witnessed new evidence about mycotoxins 
masked/modified by technological processes, especially in 
cereal-based products. Mechanical or thermal processing 
was shown to induce mycotoxin reactions with 
macromolecules such as polysaccharides and proteins or 
decomposition of their modified form and the release of a 
free mycotoxin (17, 18).
Recent research using advanced techniques based on 
mass spectrometry (MS) has detected and confirmed a 
number of modified mycotoxin derivatives. The most 
powerful technique among them is liquid chromatography 
coupled to orbitrap high resolution mass spectrometry (LC-
HRMS), which has pointed to a whole new range of possibly 
masked mycotoxins (19) that have later been confirmed by 
triple quadrupole (QqQ) mass spectrometry analyser in real 
wheat (20) and human urine samples (21). Beside these, 
liquid chromatography/tandem mass spectrometry (LC-MS/
MS) has confirmed the existence of theoretical molecules 
such as DON-glutathione conjugates in cereals, first 
synthesised and characterised by nuclear magnetic 
resonance spectroscopy (22, 23).
Despite these discoveries, there are still no directives, 
regulations, or recommendations regarding modified 
mycotoxins (11, 24). The European Food Safety Authority 
(EFSA) has emphasised the need for more occurrence data 
on modified mycotoxins in food and feed in order to assess 
exposure and the effects on human and animal health (13, 
25). In addition, the latest zearalenone (ZEN) risk 
assessment (26) included the modified forms of ZEN and 
confirmed even higher toxicity than that of the parent 
mycotoxin. The aim of this review is to describe the current 
knowledge about common modified mycotoxins, their 
formation, occurrence, analytical aspects, and toxicology.
FORMATION OF MODIFIED 
MYCOTOXINS
Biological modifications of mycotoxins through 
conjugation by plants or fungi as well as modifications 
caused by food processing can be the main contributors to 
food and feed contamination levels (11). Table 1 gives an 
overview of the most common modified mycotoxins and 
their profile, including the matrices in which they usually 
occur.
Conjugation by plant
To protect themselves from xenobiotics such as 
mycotoxins, plants trigger a detoxification process (7, 11) 
consisting of the following three stages: transformation, 
solubilisation, and compartmentalisation. In the first stage, 
xenobiotics undergo hydrolysis, reduction or oxidation, 
which form reactive groups in the xenobiotic structure. This 
stage is typical for lipophilic compounds, which become 
more hydrophilic. When foreign substances, such as the 
hydrophilic ones, already possess reactive groups, 
detoxification skips the first stage and immediately starts 
with the second. In the second stage, xenobiotics are 
conjugated with endogenous molecules such as sugars, 
sulphates, or amino acids. Formed conjugates are more 
polar than the original xenobiotic molecule, which 
facilitates their compartmentalisation (the third stage) (11). 
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Figure 1 The most important mycotoxin-producing fungi with their respective conidia microphotography: a) Aspergillus flavus (NRRL 
3251); b) Fusarium verticilioides (CBS 119.825); c) Penicillium expansum (CBS 325.48); and d) Alternaria alternata (wt) grown on 
PDA agar for 7 days
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Glc levels were about 12 % of the parent mycotoxin. 
Glucoside forms of fusarenon-X (FUSX-Glc) and nivalenol 
(NIV-Glc) have been reported by Nakagawa et al. (28) in 
wheat artificially infected with Fusarium spp. They 
estimated that over 15 % of fusarenon-X (FUSX) and 
nivalenol (NIV) are converted into glucosides. NIV-Glc 
occurrence in wheat was also reported by the EFSA (13). 
Nakagawa et al. (29) also found neosolaniol-glucoside 
(NEO-Glc) and diacetoxyscirpenol-glucoside (DAS-Glc), 
glucosides derived from type A trichotecenes, in corn 
powder mycotoxin reference material. The existence of 
oligoglycosylated forms of deoxynivalenol (DON) has been 
reported by Zachariasova et al. (30) in beer, malt, and bread 
This prevents harmful interaction between conjugated 
xenobiotics and plant components. Even so, these 
conjugates persist in plants long enough to have important 
toxicological consequences for their consumers. It has been 
suggested that some plant conjugates undergo hydrolysis 
after ingestion, thereby releasing the unconjugated parent 
mycotoxins (7, 11).
Beside the above mentioned ZEN14Glc and DON3Glc, 
there are several other plant conjugates identified and 
characterised in both artificial and natural samples. 
Lattanzio et al. (27) were the first to report T-2-glucoside 
(T-2-Glc) and HT-2-glucoside (HT-2-Glc) presence in 
naturally contaminated wheat and oats. T-2-Glc and HT-2-
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Figure 2 Mycotoxin systematisation proposed by Rychlik et al. (12)
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samples. More highly glycosylated forms of T-2 and HT-2 
were also reported in corn by Nakagawa et al. (31).
Except for the typical glucolysated mycotoxin forms, 
other mycotoxin glycosides can occur, formed through 
conjugation by sulphatase (i.e. deoxynivalenol-suflates, 
DON3Sulf and DON15Sulf) (20) or glutathione 
S-transferase (19, 22). A glutathione DON adduct (DON-
GSH), together with a range of related conjugates, has been 
investigated by Uhlig et al. (24) in naturally contaminated 
grain. The authors managed to identify glutathione (GSH), 
c y s t e i n y l g l y c i n e  ( C y s G l y ) ,  c y s t e i n e  ( C y s ) , 
γ-glutamylcysteine (γ-GluCys), and N-acetylcysteine 
(NAC) coupled at the 13th position on the epoxy group in 
the DON molecule, which was the first report of in vivo 
conjugation of trichotecenes via their epoxy group, 
generally considered as unreactive. Since DON-GSH is 
likely to be nontoxic and its formation irreversible, it was 
suggested that the identification of cereal genotypes that 
utilise the GSH-conjugation pathway may be useful in the 
future breeding strategies aiming to decrease DON 
accumulation in cereals (24). On the other hand, enhancing 
resistance to Fusarium spp. head blight (FHB) in wheat, 
often regarded as the best option to reduce fungal 
colonisation and mycotoxin contamination, showed to have 
an unexpected effect on masked mycotoxin content. 
According to Lemmens et al. (32), FHB-resistant wheat 
lines can metabolise DON to DON3Glc and decrease both 
DON and DON3Glc contamination. However, increased 
FHB resistance together with a decrease in DON content 
results in a conjugate increase in the relative fraction of the 
masked toxin compared to the parent. Such result is 
explained by the fact that increasing FHB resistance makes 
the reduction of DON content more efficient than the 
reduction of DON3Glc contamination.
In addition, other mycotoxin forms can occur, such as 
a mixed sulphate/glucoside diconjugate of a mycotoxin first 
reported by Soukup et al. (33) in 2016. The conjugates were 
found in tomato tissues and tobacco suspension cells 
inoculated with Alternaria toxins [alternariol (AOH), 
alternariomethyether (AME), tenauzonic acid (TEA), 
tentoxin (TTX) and others]. Regarding the fact that they 
can be formed by all mycotoxins and their phase I 
metabolites with two or more hydroxyl groups, the authors 
suggested that diconjugates should be taken into account 
in future modified mycotoxin analyses.
Conjugation by fungi
3-acetyl-deoxynivalenol (3Ac-DON) and 15-acetyl-
deoxynivalenol (15Ac-DON) are well known fungal 
conjugates. The production of these two biosynthetic 
precursors of DON was studied by Alexander et al. (34), 
who have elucidated the genetic basis for the difference 
between the 3- and 15Ac-DON chemo type. It was later 
found in a study with F. graminearum (11) that it is an 
esterase encoded by TRI8 which mediates the acetylation 
of trichotecene biosynthetic intermediates 3 and 15-diacetyl-
DON at either the C-3 or C-15 position, and that its 
differential activity determines 3Ac-DON or 15Ac-DON 
formation. 3Ac-DON and 15Ac-DON have generally been 
reported to occur together with DON (25). According to 
the EFSA opinion of 2013 (25), the average contribution 
of 3Ac-DON to the sum of DON and its derivatives was 
<2 % at the lower-bound estimate and 13-20 % at the upper 
bound estimate, and of 15Ac-DON 10-15 % at both lower 
and upper bound estimates. As early as 1975, Yoshitzawa 
and Morooka (35) made one of the first attempts to elucidate 
acetyl transformation of DON by trichothecene-producing 
strains of Fusarium nivale, F. roseum, and F. solani.
FUSX is another fungal conjugate that is a precursor in 
the biosynthesis of NIV. The presence of FUSX has already 
been proven in Fusarium infected maize, even though the 
concentrations and the incidence were small (11).
Fungi also have the ability to metabolise mycotoxins 
produced by mycotoxigenic fungi. The case in point is 
zearalenone (ZEN) and the formation of zearalenone-14-
sulphate (ZEN14Sulph) in the saprobic Rhizopus fungus, 
frequently found on plants, fruits, and vegetables (11).
Conjugation by mammals
Conjugates formed by mammalian mycotoxin 
metabolism in the liver and excretion via urine are unlikely 
to play any important role in food (7) but are worth 
mentioning to get a comprehensive overview of the topic. 
Common mycotoxin conjugates produced by mammals are 
DON (36, 37) and ZEN (37–39) glucoronides and sulphates. 
Mammalian conjugates in urine can serve as biomarkers of 
exposure to certain mycotoxins. This is particularly true 
since a dose-response relationship has been established by 
Šarkanj et al. (40) in pregnant women from Croatia. A DON 
glucuronide was first suggested by Meky et al. in 2003 (41) 
and DON-3-glucoronide (D3GlcA) and DON-15-
glucoronide (D15GlcA) first identified and characterised 
in naturally contaminated urine samples and human and 
animal liver microsomes a decade later (42, 43). The third 
glucuronide, DON-7-glucoronide (D7GlcA), was suggested 
and confirmed in 2013 (40). A recent report by De Boevre 
et al. (44) added to the list another DON glucuronide, with 
a possible hydroxylation point at C-8 position.
Beside conjugation, mammalian metabolism can create 
a cleavage, such as the one of phenylalanine moiety in 
ochratoxin A (OTA), and produce ochratoxin alpha (OTα) 
(Figure 4). To eliminate OTA and OTα, animals resort to 
glucuronidation, and the new glucuronides can occur on 
several positions: OTA-acyl-GlcA, OTA-phenol-GlcA, and 
OTA-amino-GlcA. OTα is also glucuronidated and mainly 
excreted via urine as OTα-acyl-GlcA and OTα-phenol-GlcA 
(Figure 4). The conjugated forms of OTA and OTα have 
been confirmed only indirectly with and without enzymatic 
hydrolysis of biological fluids of subjects exposed to OTA 
(45).
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Food processing effects
The effects of food processing on the stability of free 
mycotoxins have been well researched, but on modified or 
unregulated mycotoxins far less so. Still, we do know that 
food processing can significantly contribute to the formation 
and the final concentrations of modified mycotoxins in 
certain food products (11, 46).
One such process is coffee roasting, which causes the 
formation of several degradation products of OTA (Figure 
4), such as 14R-ochratoxin A and 14-decarboxy-ochratoxin 
(12, 47, 48). According to Bittner et al. (47), further thermal 
reaction leads to the binding of OTA to coffee polysaccharides 
via esterification and production of OTA esters such as 
OTA-glucose ester, OTA-methyl-α-D-glucopyranoside 
ester, and OTA-cellobiose ester (Figure 4).
Effects of extrusion on mycotoxins depend on time and 
temperature of the process, as well as on other factors. In 
the case of fumonisins (FBs) (Figure 5), the presence of 
additives, reducing sugars, and sodium chloride is crucial 
(46). Studies indicate that the greatest reduction of FBs 
occurs in the presence of glucose at 160 °C or more (13, 
46, 49). In the Maillard-type reaction with reducing sugars, 
this loss in FB content likely reflects on the formation of 
degradation products N-carboxymethyl fumonisin B1 
(NCM-FB1) and N-deoxyfructosyl fumonisin B1 (NDF-
FB1) (50, 51). These fumonisin derivatives have been 
reported in maize products by Seefelder et al. (52), and their 
toxicity investigated by Hartl and Humpf (53). In addition, 
the hydrolysed form of fumonisin B1 (HFB1) created by 
the cleavage of both carballylic moieties (Figure 5) is 
commonly obtained upon alkali treatment (13, 50), for 
example in the production of traditional tortillas in South 
America (46). Due to similar chemical properties of FBs 
and HFBs, the reaction scheme proposed for the modification 
of FB1 to NCM-FB1 and NDF-FB1 can also apply for the 
modification of FBs and HFBs (Figure 5). The occurrence 
of HFBs was recently investigated by Bryła et al. (54) in 
maize-based products, who concluded that the masked to 
free fumonisin concentration ratio in thermally processed 
food such as corn flakes and various snacks was higher than 
in unprocessed products such as flour or raw popcorn grains 
due to food processing. Voss et al. (55) have also confirmed 
that extrusion and nixtamalisation can reduce FB toxicity 
through hydrolysation. In 2017, Bryła et al. (56) investigated 
the effect of pH and baking temperature on the stability of 
FBs in a maize product and confirmed that FBs are 
decomposed to HFBs and partly hydrolysed FBs. Thermal 
processing of up to 250 °C, did not, however, degrade the 
FBs. The authors also detected that only 20 % of FBs were 
bound and that lower dough pH increased the bound FB 
content. Earlier, the same group of authors found FBs 
physically entrapped into the structure of macromolecular 
components such as starch during bread making (57). These 
FBs were entrapped in a gluten-free bread up to 80 % of 
the parent form. They have also reported a smaller decrease 
in the content of hidden FBs compared to the free molecules, 
which was explained by a matrix stabilisation effect (57). 
In addition, these forms of FBs formed through an 
associative interaction between the toxin and matrix 
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Figure 4 The structures of ochratoxin A, its metabolites, and processing by-products (45, 91)
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macroconstituents are in the literature often called “hidden”, 
while the above mentioned FBs, covalently linked to any 
matrix constituents, are referred to as “bound” (58-60). 
Even though the entrapping mechanism is still to be clarified 
from the physicochemical point of view, the existing data 
indicate that biopolymers such as amylose and amylopectin 
can form inclusion complexes with FBs. These forms can 
easily degrade under in vitro digestion conditions and are 
therefore toxicologically relevant (50).
The fate of DON and DON3Glc during bread making 
was studied by several other authors (30, 61-63). Vidal et 
al. (61) reported that baking reduced the concentration of 
DON but increased that of DON3Glc. They attributed this 
rise to glycosidation of DON in the initial stages of baking, 
before enzyme inactivation. This hypothesis is supported 
by the fact that DON3Glc also increases during fermentation, 
as previously suggested by Zachariasova et al. (30). The 
most recent, 2017 study by Generotti et al. (17) investigated 
the effects of baking on the final trichotecene (DON, 
DON3Glc, and Fusarium metabolite culmorin) content by 
modifying technological parameters and recipe ingredients. 
The results suggest that pH and baking time have an 
important role in minimising mycotoxins in the final 
product, while changes in the recipe can change mycotoxin 
extractability by affecting biscuit microstructure. Higher 
pH during wholegrain biscuit production reduced DON 
concentrations. Baking time effectively reduced DON and 
DON3Glc content in the final product (up to 80 %). 
Culmorin concentrations positively correlated with DON.
Beer production, in turn, raises great concern about 
possible formation and transfer of Fusarium mycotoxins 
from raw materials to final beer products (13, 46). A 
significant increase in the level of DON3Glc was observed 
during malting and brewing (64, 65). An increase was also 
observed in the levels of acetylated DON forms (AC-DONs) 
across the beer production chain (64). Their levels in barley 
were about 40 % of free DON, while in beer they were 
comparable or higher (64, 66). Even though there are several 
theories explaining the increase in DON3Glc, there are two 
phenomena that should be considered. The first includes de 
novo growth of Fusarium spp. during malting, accompanied 
by the production of additional mycotoxins and their 
transformation products. The second phenomenon relates 
to the degradation of cell walls, membrane-bound proteins, 
and starch depots by enzymes produced during mashing of 
malt grits, which leads to releasing DON3Glc from 
insoluble forms (18, 65).
Recently, Karlovsky et al. (67) gave an overview of 
how food processing and detoxification treatments relate 
to mycotoxin contamination. In some cases, food processing 
reduces mycotoxin content, such as cleaning, milling, 
brewing, fermentation, cooking, baking, roasting, alkaline 
cooking, nixtamalisation, and extrusion. However, food 
processing can seldom completely eliminate mycotoxins 
from a food product. The authors pointed out that the 
disappearance of parent mycotoxin does not necessarily 
mean detoxification because of its conversion into a 
“masked” form that escapes detection and has unknown 
toxic potential. They also allowed the possibility of co-
contamination with other mycotoxin-producing fungi (63).
OCCURRENCE
The information on mycotoxin occurrence in food and 
feed is crucial for the assessment of consumer exposure and 
for setting maximum regulatory levels for certain products. 
It is general perception that mycotoxin levels have been 
underestimated exactly because of the modified mycotoxins 
(48). Over the past few years, however, the occurrence of 
the modified forms has been extensively researched, 
DON3Glc and ZEN14Glc in particular. Malachová et al. 
(68) monitored the occurrence of several mycotoxins in 116 
cereal-based products from the Czech market. DON was 
found in 75 % of samples with its levels varying between 
13 and 594 μg kg-1, while the prevalence of DON3Glc was 
even higher (80 %) and its levels ranged between 5 and 
72 μg kg-1. The latter was found in a single whole-grain 
slice product (68).
The occurrence of DON, DON3Glc, and 3Ac-DON in 
beer was investigated by Varga et al. (66). 3Ac-DON was 
not found in any of 384 beer samples from 38 countries, 
but DON3Glc and DON were found in 93 and 77 % of the 
samples, averaging 6.9 µg L-1 and 8.4 µgL-1, respectively.
De Boevre et al. (69) analysed 30 food and feed samples 
(maize, wheat, oats, cornflakes, and bread) from Belgium 
for ZEN, ZEN14Glc, DON, DON3Glc, and AC-DON. DON 
was the most common contaminant in both cereals and 
cereal-derived food. 3Ac-DON and 15Ac-DON were found 
in 87 % and 73 % of the samples, respectively. 66 % of the 
analysed samples were contaminated with DON3Glc, with 
the highest levels in maize samples (max. 1003 µg kg-1). 
Regarding the DON equivalents, of the total DON content, 
62 % were metabolites, whereof 17 % were the glycosylated 
form DON3Glc. The occurrence of ZEN was 80 %, while 
its glycosylated and sulphated forms were detected in 40 % 
of the samples (69).
Cereal-based products (fibre-enriched bread, bran-
enriched bread, breakfast cereals, popcorn, and oatmeal) 
from Belgium were also analysed by De Boevre et al. (44) 
for the occurrence of DON, DON3Glc, AC-DONs, T-2, 
HT-2, and ZEN and its conjugates. All 174 samples were 
co-contaminated with three to eight mycotoxins, including 
one to three modified forms. DON was the major 
contaminant of wheat-based matrices. DON3Glc was found 
in half of the fibre-enriched bread samples and breakfast 
cereal samples and in 77 and 92 % of popcorn and oatmeal 
samples, respectively. The highest prevalence of AC-DONs 
was recorded in popcorn, followed by oatmeal samples, 
and 3Ac-DON was more frequent than 15Ac-DON. ZEN 
prevalence was the highest in oatmeal samples (62 %), 
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while that of ZEN conjugates was the highest in breakfast 
cereal samples (roughly 30 %).
An extensive global research of animal feed 
contamination by mycotoxins by Kovalsky et al. (1), that 
included 1113 samples (of finished feed, maize, and maize 
silage) collected between 2012 and 2015 from 44 countries 
and analysed for 57 mycotoxins and metabolites, showed 
that the regulated toxins, DON, ZEN, and to a certain extent 
FBs had the highest levels. ZEN contaminated 88 % of the 
investigated matrices and DON 79 %. The prevalence of 
the related masked forms ZEN14Sulph and DON3Glc was 
also high: 47 % and 70 %, respectively. The authors also 
established a positive correlation between DON and ZEN 
and their masked forms. In addition, the authors observed 
distinct trends of mycotoxin occurrence within a region 
over the years, suggesting the importance of cultivars and 
local weather (1).
Even though the data on the occurrence of modified 
mycotoxins are coming to light all over the world, this 
cannot be said for Croatia. There are only a few reports of 
masked mycotoxin levels in Croatian cereals: 47.8 µg kg-1 
for DON3Glc and 176.6 µg kg-1 for DON3Glc in wheat 
(40), and 546 µg kg-1 for DON3Glc and 788 µg kg-1 for 
DON3Glc in maize (70).
ANALYTICAL ASPECTS
Obviously, there are no accurate data on the occurrence 
of free and modified mycotoxins without reliable analytical 
methods. There are many chromatographic methods, mainly 
based on liquid chromatography (LC), and immunochemical 
methods, such as enzyme-linked immunosorbent assays 
(ELISA), that provide reliable measurement of free 
mycotoxins. However, the latter are still not selective 
enough for modified mycotoxins, as they sometimes 
respond to more than one compound and yield a single, 
fake positive, or overestimated result (7, 12, 13). This 
“cross-reactivity” effect was evidenced for DON, AC-
DONs, and DON3Glc. The latter two can contribute to 
DON content overestimation in some matrices (7, 71). Yet, 
cross-reactivity can be useful in determining modified 
mycotoxins. For instance, commercially available 
immunoaffinity columns (IACs) for DON analysis are 
known to cross-react with its analogues DON3Glc, 15Ac-
DON, and 3Ac-DON to a variable extent, which can be a 
valuable tool for evaluating total DON content in samples 
(72).
In general, mycotoxin analysis is a complex process 
which requires proper sampling (strategies), sample 
preparation, detection, and quantification by means of 
suitable analytical instruments. Sample preparation implies 
extraction of the toxin from the matrix with suitable solvent, 
clean-up of the extract in order to eliminate interferences 
from the matrix, and sample concentration if necessary. The 
analysis of modified mycotoxins is even more complicated 
and usually involves one of the two approaches: direct or 
indirect (7, 12, 13). The direct approach employs the 
conventional, standardised methods developed for free 
mycotoxin determination but adjusted and optimised to suit 
the properties (polarity, extraction behaviour, detection 
characteristics) of targeted modified mycotoxins. The major 
drawback of the direct approach is the lack of analytical 
standards necessary for the analysis of all masked or 
modified forms of mycotoxins. The indirect approach, in 
turn, is usually based on chemical and/or enzyme treatment 
to transform modified forms into their parent mycotoxin, 
which can then be determined with routine analysis. The 
downside is that the information it provides does not 
distinguish between free and modified mycotoxins.
This is why direct LC-MS methods have become 
methods of choice when it comes to modified mycotoxin 
determination (12). For over a decade, LC-MS/MS has been 
the golden standard for routine food safety control, as it 
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Figure 5 Formation of N-carboxymethyl-fumonisins
The structures of fumonisin B1-6 (FB1-6); hydrolysed fumonisin B1-6 (HFB1-6); N-carboxymethyl fumonisin B1-6 (NCM-FB1-6); 
N-deoxyfructosyl fumonisin B1-6 (NDF-FB1-6); N-carboxymethyl hydrolysed fumonisin B1-6 (NCM-HFB1-6); and N-deoxyfructosyl 
hydrolyzed fumonisin B1-6 (NDF-HFB1-6)
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ensures analytical parameters that meet the quality criteria 
required by law. Mycotoxin analysis now as a rule uses 
QqQ mass spectrometry analyser and multiple reaction 
monitoring (MRM). Being selective, mass spectrometry no 
longer requires clean-up steps and is particularly useful for 
simultaneous determination of multiple mycotoxins and 
their metabolites. The first multi-mycotoxin method was 
developed by Sulyok et al. (73) in 2006 for the quantification 
of 39 free and modified mycotoxins in wheat and maize, 
including AC-DONs, DON3Glc, ZEN14Glc, ZEN14Sulph, 
and hydrolysed FB1. More recently, Jackson et al. (74) 
developed a method for the quantification of free and 
modified mycotoxins in feed samples, and De Boevre et al. 
(69) for simultaneous determination of mycotoxins in 
cereals and cereal-derived food. In 2014, Malachová et al. 
(75) expanded Sulyok’s method (73) to the determination 
of 295 fungal and bacterial metabolites, including free and 
modified mycotoxin forms.
Yet, these QqQ methods have their limitations. Firstly, 
the number of analytes that can be analysed in a single run 
is restricted by the MS/MS quality. Secondly, only targeted 
compounds can be detected, and quantification requires the 
use of analytical standards, which limits determination of 
most modified mycotoxins (2). Thirdly, accurate mycotoxin 
quantification in different matrices requires matrix-assisted 
calibration or appropriate internal standard, and these 
standards and (certified) reference materials are still not 
widely available. There are several producers who now 
provide modified DON, T-2, HT-2, and Alternaria 
mycotoxins (Romer labs®, Toronto Research Chemicals, 
Sigma Aldrich® and others) to overcome this limitation.
Recently, full-scan techniques have been studied as a 
way to complement the QqQ methods. LC coupled to high 
resolution mass spectrometers (HRMS) has the advantage 
over QqQ, as it enables target analysis, identification of 
new non-targeted compounds, and retrospective data 
analysis (2, 13). While it may be less sensitive than QqQ, 
LC-HRMS orbitrap is regarded as a powerful tool for multi-
class, multi-analyte analysis in food safety (76). It has been 
used in a number of studies to scan for and measure modified 
DON, (19, 77) modified type A trichotecenes (29), OTA 
polysaccharide esters (47), or glycosyl derivatives of T-2 
and HT-2 (27).
However, HRMS still needs to resolve issues such as 
isobar co-elution and unknown molecule identification to 
become a fully effective food safety control tool. These 
issues have been addressed by the introduction of ion 
mobility spectrometry (IMS), which can provide a better 
insight into the formation and characterisation of novel 
modified mycotoxins, but requires further testing (2). 
Another issue of HRMS are the levels of detection, which 
are much higher than with QqQ. In practical terms, fewer 
naturally contaminated samples can be quantified by 
HRMS. Furthermore, HRMS is associated with a huge 
number of artefacts and nonspecific peaks in real samples, 
so the use of C-13-labelled standards or sample pairs is 
necessary for positive identification of new components 
(19).
In terms of mycotoxin determination in the future, 
multi-mycotoxin LC-MS/MS and LC-HRMS methods will 
continue to play an important role in screening, confirmation, 
and quantification of hundreds of fungal metabolites in food 
and feed samples and will be complemented by metabolomics 
in order to reveal the fundamental biological processes 
behind mycotoxin production and its reduction (78).
TOXICOLOGICAL RELEVANCE
Knowledge about the toxicological relevance of 
modified mycotoxins is still modest (79-81). Most of the 
concerns address the potential health effects of conjugated 
and matrix-associated mycotoxins, mainly due to indirect 
toxicity via hydrolysis to their free forms (11, 12, 79, 80).
In vitro studies
By mimicking natural conditions during digestion, in 
vitro studies examine the fate of modified mycotoxins in 
contact with stomach juices and interaction with human 
colonic microbiota. So far, these studies have mostly 
focused on the derivatives of ZEN and DON (11, 12). A 
2013 study by Dall’Erta et al. (79) has been the first to 
demonstrate that DON and ZEN conjugates are effectively 
cleaved by the human colonic microbiota. In the process 
they release their aglycones and generate unidentified 
catabolites. The authors showed nearly the full recovery of 
DON3Glc, ZEN14Glc, and ZEN14Sulph by enzymatic 
treatments (99.5 %, 97.3 %, and 98.6 %, respectively). The 
effects of human colonic microbiota were analysed in the 
first 30 min and at 24 h of fermentation. The ZEN 
derivatives were completely cleaved after 30 min, while 
ZEN was only partially recovered in the faecal slurry (39 % 
after 30 min and 40 % after 24 h), which implied the 
possibility of further ZEN degradation into unknown 
compounds. DON3Glc was almost completely degraded 
after 24 h (11, 79).
In 2016, Cirlini et al. (82) reported that ZEN14Glc and 
its positional isomer ZEN16Glc crossed the cell barrier and 
were absorbed by Caco-2 cells in a time- and concentration-
dependent manner. The conjugates were cleaved to release 
the parent molecule, and ZEN14Glc was more prone to 
deglycosylation than ZEN16Glc. The authors also showed 
that human cytosolic b-glucosidase cleaved ZEN14Glc but 
not ZEN16Glc, and that ZEN14Glc and ZEN16Glc were 
hydrolysed inside the cell. This implies that ZEN generated 
in situ can be taken up by intestinal cells and metabolised 
into phase I and phase II metabolites, which can contribute 
to the overall oestrogenic load.
Pierron et al. (83) also used Caco-2 cells to assess the 
ability of DON3Glc to elicit a ribotoxic stress and induce 
intestinal toxicity. DON3Glc did not bind to the main targets 
of DON toxicity and therefore did not activate JNK and 
Kovač M, et al. Yesterday masked, today modified; what do mycotoxins bring next? 
Arh Hig Rada Toksikol 2018;69:196-214
210
P38 MAPK pathways in Caco-2 cells or change their 
viability and barrier function. The authors concluded that 
glucosylation of DON suppressed its ability to bind to the 
ribosome and decreased its intestinal toxicity.
One in vitro digestion assay proved the stability of FB 
covalent conjugates (bound fumonisins) (59), while another 
(84) showed that FBs forming complexes with matrix 
macroconstituents (hidden FBs) released their free forms 
and became available for intestinal absorption. The static 
model used by Dall’Erta et al. (79) was also used to analyse 
modified FBs. These studies suggest that even if FB levels 
in products do not exceed the legal limit, digestion can 
increase their bioavailability through hidden FBs. This 
brings us back to the need to include masked mycotoxins 
in any serious risk assessment.
Considering that the intrinsic cytotoxicity of modified 
DON3Glc, 3Ac-DON, and 15Ac-DON (AC-DONs) has 
not been investigated as extensively as of their parent 
mycotoxins, Broekaert et al. (85) compared their in vitro 
cytotoxicity towards differentiated and proliferative porcine 
intestinal epithelial line derived from the jejunum 
(IPEC-J2). The cytotoxicity of DON and its modified forms 
after a 72-hour exposure was as follows: DON3Glc<<3Ac-
DON<DON≈15Ac-DON. The authors, however, 
emphasized that cytotoxicity to IECs was only one 
toxicological endpoint, while other, such as the effects on 
the immune system, could have significantly more or less 
sensitive dose-response curves.
Beside in vitro studies, Dellafiora et al. (86) carried out 
an in silico study to gain an insight into the systemic fate 
of ZEN14Glc. They monitored the hydrolysis and the 
transformation of the masked mycotoxin in bovine blood 
and blood components. All matrices showed hydrolysis, 
and the whole blood showed ZEN isomers. Further 
assessment of (bio)transformation in the blood stream is 
needed to better understand the in vivo action of ZEN and 
its modified forms.
In vivo studies
The first reported study on modified mycotoxins in vivo 
comes from 1990, when Gereis et al. (87) noted a 
decomposition of ZEN14Glc in pigs and detected ZEN and 
its metabolites in urine and faeces. Although they evidenced 
the complete hydrolysis of ZEN14Glc, they found no 
associated clinical signs of oestrogenic activity. Two 
decades later, Veršilovskis et al. (88) reported unstable 
ZEN14Glc in rat stomach (35 % and 46 % were recovered), 
which rapidly hydrolysed to free ZEN. In the intestine only 
small amounts of ZEN14Glc were observed (0.5 % in the 
small intestine, 2.5 % in the colon). Both studies evidence 
that ZEN14Glc is rapidly hydrolysed in vivo and that its 
contribution to overall mycotoxin toxicity is highly 
probable. However, to fully understand toxicokinetics and 
species differences further research is needed (80, 81).
Veršilovskis et al. (88) also reported 37 % and 51 % 
recovery of DON3Glc in the stomach, whereas the release 
of DON was only 2 %. In the small and large intestine no 
free DON and small traces of DON3Glc were found. In 
another study by Nagl et al. (89) only a very small 
percentage of DON3Glc was found in urine after 
administration, while the majority was found in faeces, 
indicating that faecal excretion is the major route of 
DON3Glc elimination in rats. The authors have suggested 
that DON3Glc in food and feed is less toxic than DON but 
have also allowed that its bioavailability and metabolism 
are species-dependent due to differences in the anatomy 
and gut microbiota. Two years later the same group of 
authors (90) studied the possibility of DON3Glc cleavage 
during ingestion in pigs. After the oral dosing of DON3Glc, 
urinary DON was the main excretion product after 24 h, 
while only trace amounts of the metabolite were found in 
faeces. These findings indicate that DON3Glc is almost 
completely hydrolysed in the gastro-intestinal tract of pigs. 
Compared to its parent form, DON3Glc seems to be less 
bioavailable and therefore less relevant toxicologically. 
However, the authors emphasised the possibility of 
DON3Glc having a biological activity of its own, which 
deserved more attention.
CONCLUDING REMARKS
The term masked mycotoxin was initially used to 
highlight difficulties in the detection of certain compounds 
by routine analysis. To avoid misunderstanding and 
introduce uniform interpretation, especially in legislation, 
the term has been limited to cover only biologically 
modified mycotoxins conjugated by plants.
Mass spectrometers brought the possibility to analyse 
several mycotoxins at once and simplified the discovery of 
novel compounds. Consequently, it has become evident that 
modified mycotoxins co-exist with their native compounds 
in contaminated agricultural commodities, sometimes in 
the same or even higher level. This has raised the question 
of their toxicological relevance and adverse health effects. 
Toxicological studies have confirmed that certain modified 
mycotoxins are hydrolysed into their free forms after the 
ingestion. However, further research is needed to fully 
clarify their fate upon ingestion. Their physiological and 
toxicological role should also be assessed, because some 
of the toxins may not act as their parent compound. The 
outcome of these toxicological researches will hopefully 
drive the legislators to expand regulations to encompass 
both free and modified mycotoxins.
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Jučer maskirani, a danas modificirani – što je sljedeće s mikotoksinima?
Mikotoksini su sekundarni metaboliti toksigenih plijesni široko rasprostranjenih u usjevima. Biljke, životinje, bakterije 
i plijesni posjeduju sposobnost modifikacije mikotoksina, a do nje može doći i tijekom obrade hrane, što rezultira nastankom 
velikog broja „maskiranih” oblika mikotoksina. Tako modificirani oblici mikotoksina često ostaju nevidljivi pri različitim 
analitičkim tehnikama, što utječe i na točnu procjenu rizika jer se nakon konzumacije kontaminiranih namirnica modificirani 
oblici mikotoksina u probavnom sustavu vraćaju u izvorni oblik. To je dovelo do potrebe za analitičkim tehnikama kojima 
se mogu detektirati i kvantificirati modificirani oblici mikotoksina. Sprega tekućinske kromatografije i spektrometrije 
masa (LC-MS/MS) analitička je tehnika detekcije koja najviše obećava, a za otkrivanje novih modificiranih spojeva 
uglavnom se primjenjuju spektrometri masa visoke rezolucije. Unatoč tome, toksični utjecaj modificiranih oblika 
mikotoksina još nije do kraja razjašnjen. 
KLJUČNE RIJEČI: LC-MS/MS; LC-HRMS; sekundarni metaboliti plijesni; toksikologija
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